News

GHK-Cu and Thymalin After the FDA Panel Vote: C...

Exploring the research behind GHK-Cu and Thymalin synergy for longevity after the FDA panel vote, from Soviet trials to epigenetic and immune aging

NAD+ and Vesugen After the FDA Panel Vote: Can ...

After the FDA panel vote, researchers are asking whether NAD+ and Vesugen can still support vascular rejuvenation. This article examines the science

GHK-Cu vs. Vesugen for Vascular Aging: Copper P...

GHK-Cu and Vesugen target vascular aging through different mechanisms: copper-dependent matrix remodeling versus gene reactivation. Preclinical data

NAD+ and Epitalon After the FDA Panel Vote: Can...

After the FDA panel vote on phenylephrine, questions arise about compounded peptides like NAD+ precursors and Epitalon. This article examines

GHK-Cu After Laser Resurfacing: Accelerating Sk...

Can GHK-Cu accelerate skin remodeling after laser resurfacing? This article examines how the copper peptide guides healing toward regeneration, the

GHK-Cu and Epitalon Synergy for Telomere Support

Can GHK-Cu's gene-resetting effects amplify Epitalon's telomerase activation? This article explores the intersecting pathways of NAD+, sirtuins, and